Takeda shunts jewel of Shire takeover to new spinoff Oak Hill
Takeda shunts jewel of Shire takeover to new spinoff Oak [...]
Gamida Cell readies stem cell transplant therapy for FDA submission but seeks strategic partners amid staffing cuts
Gamida Cell readies stem cell transplant therapy for FDA submission [...]
Madrigal’s NASH prospect clears first phase 3 test, raising hopes it can magic up positive pivotal efficacy data
Madrigal’s NASH prospect clears first phase 3 test, raising hopes [...]
Pfizer ends $3B drug dream despite phase 2b success, leaving Regeneron with a clear run at cardiovascular market
Pfizer ends $3B drug dream despite phase 2b success, leaving [...]
UPDATE: Kaleido confirms layoffs, halts planned phase 2 and appears to have ended COVID-19 program
UPDATE: Kaleido confirms layoffs, halts planned phase 2 and appears [...]
Charles River Labs deals with SAMDI Tech to boost discovery business
Charles River Labs deals with SAMDI Tech to boost discovery [...]
Yet another delay at Amryt as EMA calls in experts to inform review of rare disease drug
Yet another delay at Amryt as EMA calls in experts [...]
Homology scratches cash itch with manufacturing deal, bagging $130M to fund gene therapy trials
Homology scratches cash itch with manufacturing deal, bagging $130M to [...]
Taysha mulls tweaks to gene therapy trial after subject dies
Taysha mulls tweaks to gene therapy trial after subject dies [...]
Neck and neck with Pfizer, Moderna gives first dose of omicron-specific booster in phase 2 trial
Neck and neck with Pfizer, Moderna gives first dose of [...]